CABA · Cabaletta Bio, Inc. · Share Buybacks
$2.97
-0.30 (-9.30%)
At close · Sep 9
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we have concluded that substantial doubt exists about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$565.43M
Shares
169.55M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-07 | — | $150,000,000 | — | — | 10-Q , filed 2025-11-10 |
Key facts
CIK
1759138
CUSIP
12674W109
13F (30d)
104 filings
104 filers
Visit website
Investor relations